Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-09-30 to 2024-02-29
Current total value of award: $777500
Description: LABORATORY TESTING. SECTION 711  (NDAA) 2019 THE (USAMRAA), U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND (USAMRDC) TRANSFERRED TO THE DEFENSE HEALTH AGENCY (DHA) FROM THE U.S. ARMY EFFECTIVE 01 OCTOBER 2022